Chinese cancer test provider Burning Rock Biotech sets terms for $196 million US IPO

, , Comments Off on Chinese cancer test provider Burning Rock Biotech sets terms for $196 million US IPO

Burning Rock Biotech, which provides DNA sequencing-based cancer therapy selection tests in China, announced terms for its IPO on Friday. The company plans to raise an additional $25 million in a …
( read original story …)